These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38809631)

  • 1. Association between CTX-1 and Fibulin-1 Serum Levels with Pathogenesis of Multiple Myeloma Cancer.
    Mohammed Ali Abed Al-Janabi A; Momeni HR; Jasim Obaid Al-Harbi H
    Asian Pac J Cancer Prev; 2024 May; 25(5):1599-1605. PubMed ID: 38809631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procollagen I amino-terminal propeptide as a potential marker for multiple myeloma.
    Kowalska M; Druzd-Sitek A; Fuksiewicz M; Kotowicz B; Chechlinska M; Syczewska M; Walewski J; Kaminska J
    Clin Biochem; 2010 Apr; 43(6):604-8. PubMed ID: 20045402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of C-terminal telopeptide of type 1 collagen in multiple myeloma.
    Ting KR; Brady JJ; Hameed A; Le G; Meiller J; Verburgh E; Bayers C; Benjamin D; Anderson KC; Richardson PG; Dowling P; Clynes M; Fitzgibbon MC; O'Gorman P
    Br J Haematol; 2016 Apr; 173(1):82-8. PubMed ID: 26787413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for bone turnover markers β-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma.
    Vallet S; Hoyle NR; Kyle RA; Podar K; Pecherstorfer M
    Leuk Lymphoma; 2018 Oct; 59(10):2431-2438. PubMed ID: 29345175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on diagnostic value of P1NP and β-CTX in bone metastasis of patients with breast cancer and the correlation between them.
    Zuo CT; Yin DC; Fan HX; Lin M; Meng Z; Xin GW; Zhang YC; Cheng L
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5277-5284. PubMed ID: 31298379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics of bone disease in multiple myeloma and clinical significance of monitoring bone metabolic markers].
    Chu B; Lu MQ; Wu MQ; Shi L; Fu LN; Gao S; Fang LJ; Xiang QQ; Bao L
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1424-9. PubMed ID: 27266350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between serum bone metabolism indexes and bone disease and survival in newly diagnosed multiple myeloma patients.
    Huang L; Zhong Y; Chen Q; He D; Zheng G; Yang Y; Han X; Wu W; Zhao Y; Li Y; Yang L; Cai Z; He J
    Cancer Biol Ther; 2024 Dec; 25(1):2403205. PubMed ID: 39295128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma.
    Elomaa I; Virkkunen P; Risteli L; Risteli J
    Br J Cancer; 1992 Aug; 66(2):337-41. PubMed ID: 1503907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of serum bone metabolic markers in diagnosis and monitoring of myeloma bone disease].
    Peng F; Fu R; Liu H; Wang Y; Ding K; Ding S; Liu Z; Ruan E; Qu W; Wang H; Xing L; Wang X; Wang G; Song J; Wu Y; Li L; Liu H; Guan J; Shao Z
    Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(42):3436-9. PubMed ID: 26813134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D deficiency linked to abnormal bone and lipid metabolism predicts high-risk multiple myeloma with poorer prognosis.
    Bao L; Wang YT; Lu MQ; Chu B; Shi L; Gao S; Fang LJ; Xiang QQ; Ding YH; Liu X; Zhao X; Wang MZ; Chen Y; Hu WK
    Front Endocrinol (Lausanne); 2023; 14():1157969. PubMed ID: 37181039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of carboxy-terminal telopeptide of type-I collagen are elevated in patients with multiple myeloma showing skeletal manifestations in magnetic resonance imaging but lacking lytic bone lesions in conventional radiography.
    Jakob C; Zavrski I; Heider U; Bollow M; Schulz CO; Fleissner C; Eucker J; Michael R; Hamm B; Possinger K; Sezer O
    Clin Cancer Res; 2003 Aug; 9(8):3047-51. PubMed ID: 12912955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma.
    Scudla V; Pika T; Budikova M; Petrova J; Minarik J; Bacovsky J; Langova K; Zivna J;
    Neoplasma; 2010; 57(2):102-10. PubMed ID: 20099972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of the ratio of serum beta-CTX/PINP in multiple myeloma bone diseases and bone metastases].
    Yang SW; Ma RJ; Zhao JJ; Yuan XL; Jiang L; Yang J; Lei PC; Zhang Y; Zhang L; Liu G; Wang F; Zhu ZM
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(32):2583-2587. PubMed ID: 30220144
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic value of the bone turnover markers in multiple myeloma.
    Auzina D; Erts R; Lejniece S
    Exp Oncol; 2017 Mar; 39(1):53-56. PubMed ID: 28361850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone Metabolism of Multiple Myeloma Bone Disease Patients with Different Blood Separation Results].
    Fan ZW; Chu NL; Yan S; Qiao JQ; Yu QY; Zhang JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):799-804. PubMed ID: 38926970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence and clinical significance of proteasome inhibitor on serum bone metabolite markers in patients with myeloma bone disease].
    Ma RJ; Yang SW; Yuan XL; Jiang L; Yang J; Wang Z; Zhang Y; Lei PC; Zhang L; Shang BJ; Cheng LN; Zhu ZM
    Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(26):2032-2035. PubMed ID: 32654448
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patients.
    Fonseca R; Trendle MC; Leong T; Kyle RA; Oken MM; Kay NE; Van Ness B; Greipp PR
    Br J Haematol; 2000 Apr; 109(1):24-9. PubMed ID: 10848778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis.
    Garnero P; Borel O; Delmas PD
    Clin Chem; 2001 Apr; 47(4):694-702. PubMed ID: 11274020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two automated assays of BTM (CTX and P1NP) and reference intervals in a Danish population.
    Jørgensen NR; Møllehave LT; Hansen YBL; Quardon N; Lylloff L; Linneberg A
    Osteoporos Int; 2017 Jul; 28(7):2103-2113. PubMed ID: 28455749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum 25(OH)D is associated with an altered bone turnover marker response after a hip fracture.
    Stewart CC; O'Hara NN; Orwig D; Hochberg MC; Sprague S; Magaziner J; Slobogean GP
    J Orthop Res; 2019 Mar; 37(3):535-540. PubMed ID: 30578572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.